{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:35:08Z","timestamp":1761561308707},"reference-count":92,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.4065\/71.12.1182","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:08:23Z","timestamp":1232759303000},"page":"1182-1191","source":"Crossref","is-referenced-by-count":47,"title":["Cyclosporine in the Treatment of Dermatologic Disease: An Update"],"prefix":"10.4065","volume":"71","author":[{"given":"Katherine K.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.P. Daniel","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold L.","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace J.","family":"Sabers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Pittelkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/71.12.1182_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.4065\/71.12.1182_bib2","first-page":"1434","article-title":"Sandimmun Neoral pharmacokinetics: impact of the new oral formulation","volume":"27","author":"Holt","year":"1995","journal-title":"Transplant Proc"},{"key":"10.4065\/71.12.1182_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0190-9622(90)70358-O","article-title":"The role of cytochromes P-450 in cyclosporine metabolism","volume":"23","author":"Watkins","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0190-9622(90)70354-K","article-title":"Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist","volume":"23","author":"Mockli","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib5","first-page":"60","article-title":"Therapeutic monitoring of cyclosporine","volume":"24","author":"Woo","year":"1994","journal-title":"Ann Clin Lab Sci"},{"key":"10.4065\/71.12.1182_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.6334364","article-title":"Induction of interleukin 2 messenger RNA inhibited by cyclosporin A","volume":"226","author":"Elliot","year":"1984","journal-title":"Science"},{"key":"10.4065\/71.12.1182_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.4065\/71.12.1182_bib8","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc Nati Acad Sci USA"},{"key":"10.4065\/71.12.1182_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.1700475","article-title":"Probing immunosuppressant action with a nonnatural immunophilin ligand","volume":"250","author":"Bierer","year":"1990","journal-title":"Science"},{"key":"10.4065\/71.12.1182_bib10","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/MCB.13.8.4760","article-title":"Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location","volume":"13","author":"Bram","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.4065\/71.12.1182_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.4065\/71.12.1182_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-5699(93)90061-O","article-title":"The mechanisms of action of cyclosporin A in the treatment of psoriasis","volume":"14","author":"Wong","year":"1993","journal-title":"Immunol Today"},{"key":"10.4065\/71.12.1182_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"NEnglJMed"},{"key":"10.4065\/71.12.1182_bib14","first-page":"366","article-title":"Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis","volume":"130","author":"Laburte","year":"1994","journal-title":"BrJDermatol"},{"key":"10.4065\/71.12.1182_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.293.6549.731","article-title":"Clearance of psoriasis with low dose cyclosporin","volume":"293","author":"Griffiths","year":"1986","journal-title":"BMJ"},{"issue":"Suppl 36","key":"10.4065\/71.12.1182_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1990.tb02878.x","article-title":"Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience","volume":"122","author":"Fradin","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.4065\/71.12.1182_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0190-9622(95)91393-9","article-title":"Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study","volume":"33","author":"Mrowietz","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib18","first-page":"90","article-title":"Intermittent cyclosporin A treatment of severe plaque psoriasis: long-term follow-up of 26 patients","volume":"186","author":"Peluso","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.4065\/71.12.1182_bib19","first-page":"92","article-title":"Short-term treatment with cyclosporin in severe psoriasis: four years of experience","volume":"186","author":"Garcovich","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.4065\/71.12.1182_bib20","first-page":"101","article-title":"Cyclical immuno-therapy in patients with psoriasis","volume":"186","author":"Amerio","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"issue":"Suppl","key":"10.4065\/71.12.1182_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000247289","article-title":"Management of erythrodermic psoriasis with low-dose cyclosporin","volume":"187","author":"Studio Italiano Multicentrico nella Psoriasi (SIMPSO)","year":"1993","journal-title":"Dermatology"},{"key":"10.4065\/71.12.1182_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0190-9622(08)80694-9","article-title":"Rapid response of von Zumbusch psoriasis to cyclosporine","volume":"23","author":"Fradin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0190-9622(08)81109-7","article-title":"Acrodermatitis continua-type of pustular psoriasis responds to low-dose cyclosporine","volume":"23","author":"Peter","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archderm.1989.01670160055007","article-title":"Cyclosporine in the treatment of psoriatic arthritis","volume":"125","author":"Gupta","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.4065\/71.12.1182_bib25","first-page":"750","article-title":"Response of nail psoriasis to cyclosporin [letter]","volume":"129","author":"Arnold","year":"1993","journal-title":"BrJDermatol"},{"key":"10.4065\/71.12.1182_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0190-9622(90)70015-A","article-title":"Intralesional cyclosporine in the treatment of psoriasis: a clinical, immunologie, and pharmacokinetic study","volume":"22","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(87)92829-7","article-title":"Topical cyclosporin and psoriasis [letter]","volume":"1","author":"Griffiths","year":"1987","journal-title":"Lancet"},{"key":"10.4065\/71.12.1182_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4362.1994.tb01533.x","article-title":"Cyclosporine in dermatology: pharmacology and clinical use","volume":"33","author":"Kauvar","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.4065\/71.12.1182_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(09)80147-3","article-title":"Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis","volume":"30","author":"Brechtel","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0190-9622(94)70138-5","article-title":"A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study","volume":"31","author":"Grossman","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2133.1996.tb06990.x","article-title":"A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses","volume":"134","author":"Bourke","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.4065\/71.12.1182_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0190-9622(90)70009-7","article-title":"Treatment of severe lichen planus with cyclosporine","volume":"22","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archderm.1989.01670220134027","article-title":"Cyclosporin A in the treatment of lichen planus [letter]","volume":"125","author":"Higgins","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.4065\/71.12.1182_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/09546638909086688","article-title":"A preliminary open study of topical cyclosporin for hypertrophie lichen planus","volume":"1","author":"Grattan","year":"1989","journal-title":"J Dermatol Treat"},{"key":"10.4065\/71.12.1182_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199008023230502","article-title":"Effect of topical cyclosporine rinse on oral lichen planus: a double-blind analysis","volume":"323","author":"Eisen","year":"1990","journal-title":"NEnglJMed"},{"key":"10.4065\/71.12.1182_bib37","first-page":"33","article-title":"Cyclosporine A, an alternative to the oral lichen planus erosive treatment","volume":"38","author":"Lopez Lopez","year":"1995","journal-title":"Bull Group Int Rech Sci Stomatol Odontol"},{"key":"10.4065\/71.12.1182_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0030-4220(94)90034-5","article-title":"Cyclosporin A in an adhesive base for treatment of recalcitrant oral lichen planus: an open trial","volume":"78","author":"Voute","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.4065\/71.12.1182_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0190-9622(08)81809-9","article-title":"Cyclosporine therapy in Beh\u00e7et's disease","volume":"29","author":"Suss","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02249016","article-title":"Cyclosporin in Beh\u00e7et's disease: results in 16 patients after 24 months of therapy","volume":"13","author":"Pacor","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.4065\/71.12.1182_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0190-9622(89)80236-1","article-title":"Cyclosporine therapy for severe atopic dermatitis","volume":"21","author":"Taylor","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporine in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.4065\/71.12.1182_bib43","first-page":"634","article-title":"Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study","volume":"130","author":"van Joost","year":"1994","journal-title":"BrJDermatol"},{"key":"10.4065\/71.12.1182_bib44","first-page":"43","article-title":"Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions","volume":"124","author":"Munro","year":"1991","journal-title":"BrJDermatol"},{"key":"10.4065\/71.12.1182_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.1994.tb02936.x","article-title":"Maintenance treatment with cyclosporin in atopic eczema","volume":"130","author":"Munro","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.4065\/71.12.1182_bib46","first-page":"136","article-title":"Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis","volume":"144","author":"de Prost","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.4065\/71.12.1182_bib47","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/archderm.1992.01680180054005","article-title":"Treatment of pyoderma gangrenosum with cyclosporine","volume":"128","author":"Matis","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.4065\/71.12.1182_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2133.1991.tb14783.x","article-title":"Clearing of pyoderma gangrenosum by intralesional cyclosporin A [letter]","volume":"125","author":"Mrowietz","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.4065\/71.12.1182_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses: a clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.4065\/71.12.1182_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000247859","article-title":"Intractable epidermolysis bullosa acquisita: efficacy of ciclosporin A","volume":"181","author":"Merle","year":"1990","journal-title":"Dermatol\u00f3gica"},{"key":"10.4065\/71.12.1182_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","article-title":"Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis","volume":"22","author":"Gupta","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09546639209092752","article-title":"Topical cyclosporin A fails to improve alopecia areata: a double blind study","volume":"3","author":"Rongioletti","year":"1992","journal-title":"J Dermatol Treat"},{"key":"10.4065\/71.12.1182_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2230.1988.tb00637.x","article-title":"Skin collagen from scleroderma patients before and after cyclosporin A treatment","volume":"13","author":"Frances","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.4065\/71.12.1182_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0733-8635(18)30385-1","article-title":"A review and update of the clinical uses of cyclosporine in dermatology","volume":"9","author":"Graisser","year":"1991","journal-title":"Dermatol Clin"},{"key":"10.4065\/71.12.1182_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02229882","article-title":"Scleroderma renal crisis as a possible complication of cyclosporin A withdrawal","volume":"13","author":"Casoli","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.4065\/71.12.1182_bib56","first-page":"176","article-title":"Persistent light reaction: successful treatment with cyclosporin A","volume":"68","author":"Duschet","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.4065\/71.12.1182_bib57","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0190-9622(92)70261-D","article-title":"Successful treatment of musk ketone-induced chronic actinic dermatitis with cyclosporine and PUVA","volume":"27","author":"Gardeazabal","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0190-9622(89)70184-5","article-title":"Actinic reticuloid: response to cyclosporine","volume":"21","author":"Norris","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000248610","article-title":"Development of cutaneous pseudolymphoma following ciclosporin therapy of actinic reticuloid","volume":"177","author":"Thestrup-Pedersen","year":"1988","journal-title":"Dermatol\u00f3gica"},{"issue":"Suppl 32","key":"10.4065\/71.12.1182_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2133.1987.tb12098.x","article-title":"Pemphigus foliaceus and response to cyclosporin","volume":"117","author":"Cunliffe","year":"1987","journal-title":"BrJ Dermatol"},{"key":"10.4065\/71.12.1182_bib61","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1365-4362.1991.tb04361.x","article-title":"The role of cyclosporine A in the treatment of pemphigus erythematosus","volume":"30","author":"Campolmi","year":"1991","journal-title":"IntJ Dermatol"},{"key":"10.4065\/71.12.1182_bib62","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0190-9622(88)70132-2","article-title":"Treatment of nine cases of pemphigus vulgaris with cyclosporine","volume":"18","author":"Barth\u00e9l\u00e9my","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib63","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(08)80749-9","article-title":"Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids [letter]","volume":"27","author":"Bianchi","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(08)80866-3","article-title":"Topical cyclosporine for cicatricial pemphigoid [letter]","volume":"28","author":"Azana","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1990.01670270129025","article-title":"Cyclosporine therapy for bullous erythema multiforme [letter]","volume":"126","author":"Wilkel","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.4065\/71.12.1182_bib66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2230.1995.tb01290.x","article-title":"Benign familial chronic pemphigus (Hailey-Hailey disease) responds to cyclosporin","volume":"20","author":"Berth-Jones","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.4065\/71.12.1182_bib67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0190-9622(08)80201-0","article-title":"Topical cyclosporine in chronic benign familial pemphigus (Hailey-Hailey disease)","volume":"27","author":"Jitsukawa","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-857X(21)00234-9","article-title":"Immunosuppressive drug therapy of systemic lupus erythematosus","volume":"20","author":"Fox","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.4065\/71.12.1182_bib70","first-page":"59","article-title":"Cyclosporine treatment for dermatomyosifis\/polymyositis","volume":"51","author":"Mehregan","year":"1993","journal-title":"Cutis"},{"key":"10.4065\/71.12.1182_bib71","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"1","author":"Heckmatt","year":"1989","journal-title":"Lancet"},{"key":"10.4065\/71.12.1182_bib72","first-page":"16","article-title":"\u201cCatch-up\u201d growth in steroid dependent dermatomyositis treated with cyclosporin-A","volume":"1","author":"Hamill","year":"1992","journal-title":"EurJMed"},{"key":"10.4065\/71.12.1182_bib73","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2165\/00003495-199345060-00007","article-title":"Cyclosporin: a review of its pharmacodynamic and pharmacokinefic properties, and therapeutic use in immunoregulatory disorders","volume":"45","author":"Faulds","year":"1993","journal-title":"Drugs"},{"key":"10.4065\/71.12.1182_bib74","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0190-9622(90)70351-H","article-title":"Cyclosporine in nonpsoriatic dermatoses","volume":"23","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0190-9622(08)81946-9","article-title":"Cyclosporine in the treatment of generalized granuloma annulare","volume":"30","author":"Filotico","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.1994.tb06886.x","article-title":"Cyclosporin A in the treatment of chronic dermatitis of the hands","volume":"130","author":"Reitamo","year":"1994","journal-title":"BrJ Dermatol"},{"key":"10.4065\/71.12.1182_bib77","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0190-9622(90)70353-J","article-title":"Management of patients and side effects during cyclosporine therapy for cutaneous disorders","volume":"23","author":"Fradin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-198701000-00008","article-title":"Cancers following cyclosporine therapy","volume":"43","author":"Penn","year":"1987","journal-title":"Transplantation"},{"issue":"Suppl6","key":"10.4065\/71.12.1182_bib79","first-page":"S21","article-title":"Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity","volume":"ll","author":"Rodicio","year":"1993","journal-title":"J Hypertens"},{"issue":"SuppI 36","key":"10.4065\/71.12.1182_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.1990.tb02883.x","article-title":"Renal function and blood pressure in psoriatic patients treated with cyclosporin A","volume":"122","author":"Feutren","year":"1990","journal-title":"BrJ Dermatol"},{"key":"10.4065\/71.12.1182_bib81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.1992.tb14848.x","article-title":"Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy","volume":"127","author":"Korstanje","year":"1992","journal-title":"BrJ Dermatol"},{"key":"10.4065\/71.12.1182_bib82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0190-9622(92)70065-N","article-title":"Morphologic renal changes during cyclosporine treatment of psoriasis: studies on pre-treatment and posttreatment kidney biopsy specimens","volume":"26","author":"Zachariae","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/71.12.1182_bib83","series-title":"Beh\u00e7et Disease: Basic and Clinical Aspects","first-page":"613","article-title":"Long-term follow-up of cyclosporin A treated patients with Beh\u00e7et disease","author":"Svenson","year":"1991"},{"key":"10.4065\/71.12.1182_bib84","first-page":"150","article-title":"Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report","volume":"43","author":"Messana","year":"1995","journal-title":"ClinNephrol"},{"key":"10.4065\/71.12.1182_bib85","first-page":"1182","article-title":"Cyclosporine-induced hypertension after transplantation","volume":"69","author":"Textor","year":"1994","journal-title":"MayoClinProc"},{"key":"10.4065\/71.12.1182_bib86","first-page":"S45","article-title":"Management of hypertension after transplantation","volume":"43","author":"Curtis","year":"1993","journal-title":"Kidney IntSuppl"},{"key":"10.4065\/71.12.1182_bib87","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI117222","article-title":"Vascular mechanisms of cyclosporin-induced hypertension in the rat","volume":"93","author":"Roullet","year":"1994","journal-title":"J Clin Invest"},{"key":"10.4065\/71.12.1182_bib88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2230.1992.tb02525.x","article-title":"How to improve the risk-benefit ratio of cyclosporin therapy for psoriasis","volume":"17","author":"Korstanje","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.4065\/71.12.1182_bib89","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00007890-199305000-00009","article-title":"Cyclosporine-ketoconazole interaction: long-term follow-up and preliminary results of a randomized trial","volume":"55","author":"First","year":"1993","journal-title":"Transplantation"},{"key":"10.4065\/71.12.1182_bib90","first-page":"163","article-title":"Cyclosporine A: review of genotoxicity and potential for adverse human reproductive and developmental effects; report of a working group on the genotoxicity of cyclosporine A, August 18, 1993","volume":"317","author":"Olshan","year":"1994","journal-title":"Mutat Res"},{"key":"10.4065\/71.12.1182_bib91","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2133.1993.tb15145.x","article-title":"Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis","volume":"128","author":"Powles","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.4065\/71.12.1182_bib92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0190-9622(89)70209-7","article-title":"Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal function","volume":"21","author":"Gilbert","year":"1989","journal-title":"J Am Acad Dermatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611647034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611647034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:21:25Z","timestamp":1709986885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611647034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0025619611647034"],"URL":"https:\/\/doi.org\/10.4065\/71.12.1182","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}